Mumps: A year of enhanced surveillance in Catalonia, Spain

Simple item page
UDC.coleccionInvestigación
UDC.departamentoMatemáticas
UDC.endPage3495
UDC.grupoInvModelización, Optimización e Inferencia Estatística (MODES)
UDC.issue25-26
UDC.journalTitleVaccine
UDC.startPage3492
UDC.volume27
dc.contributor.authorDomínguez, Àngeles
dc.contributor.authorOviedo de la Fuente, Manuel
dc.contributor.authorTorner, Nuria
dc.contributor.authorCarmona, Glòria
dc.contributor.authorCosta, Josep
dc.contributor.authorCaylà, Joan A.
dc.contributor.authorSala, M. Rosa
dc.contributor.authorBarrabeig, Irene
dc.contributor.authorCamps, Neus
dc.contributor.authorMinguell, Sofía
dc.contributor.authorÁlvarez, Josep
dc.contributor.authorGodoy, Pere
dc.contributor.authorJansà, Josep M.
dc.date.accessioned2026-02-02T12:54:48Z
dc.date.available2026-02-02T12:54:48Z
dc.date.issued2009-03-31
dc.description.abstract[Abstract]: Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in ≥15 years (p = 0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.
dc.description.sponsorshipThe other members of the Mumps Control Working Group of Catalonia are: Alsedà M., Arias C., Artigues A., Balaña J.P., Batalla J., Cardeñosa N., Ciruela P., Companys M., Follia N., Parrón I., Plasencia E., Rovira A., Torres J., Urbiztondo L. (Department of Health, Generalitat of Catalonia, Spain) and Rius C. (Public Health Agency of Barcelona, Spain). We thank the reporting physicians and technicians of the Epidemiological Surveillance Units of the Department of Health of the Generalitat of Catalonia and the Public Health Agency of Barcelona for their collaboration. This work was partially funded by CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
dc.identifier.citationDominguez, A., Oviedo, M., Torner, N., Carmona, G., Costa, J., Caylà, J., Sala, M. R., Barrabeig, I., Camps, N., & Minguell, S. (2009). Mumps: A year of enhanced surveillance in Catalonia, Spain. Vaccine, 27(25-26), 3492-3495. https://doi.org/10.1016/j.vaccine.2009.03.022
dc.identifier.doi10.1016/j.vaccine.2009.03.022
dc.identifier.issn0264-410X
dc.identifier.urihttps://hdl.handle.net/2183/47181
dc.language.isoeng
dc.publisherElsevier
dc.relation.urihttps://doi.org/10.1016/j.vaccine.2009.03.022
dc.rights© 2009 Elsevier Ltd. All rights reserved
dc.rights.accessRightsembargoed access
dc.subjectMumps
dc.subjectEnhanced surveillance
dc.subjectLaboratory confirmation
dc.titleMumps: A year of enhanced surveillance in Catalonia, Spain
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication15997118-059a-491f-b7d3-84eadf33cec5
relation.isAuthorOfPublication.latestForDiscovery15997118-059a-491f-b7d3-84eadf33cec5

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dominguez_Angela_2009_Mumps.pdf
Size:
133.63 KB
Format:
Adobe Portable Document Format
(9999-12-31) Download

Collections

Investigación (FIC)